English
Français
Español
Deutsch
Italiano
Português
Nederlands
Polski
Română
Svenska
Dansk
Suomi
Čeština
Ελληνικά
Magyar
SlovenčinaData temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 3/5 criteria met.
- ❌ Price trend failed
- ✅ Growth passed
- ✅ Debt passed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: 43.38%
Price change 2019 → 2020: 82.75%
Price change 2020 → 2021: 7.07%
Price change 2021 → 2022: -36.66%
Price change 2022 → 2023: 3.75%
Price change 2023 → 2024: -14.87%
Price change 2024 → 2025: -33.44%
Price change 2025 → 2026: 3.04%
Price change 2026 (year to date): 4.06%
Financial growth
Revenue CAGR (8 years): 10.71%
Earnings CAGR (8 years): 21.20%
Growth status: positive trend (>1%/yr) in revenue and earnings.
Debt
Debt-to-equity ratio: 0.04
Debt/equity < 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 9.69
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 6.82% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| NICE Ltd. | 10.3 | 0.02 | +10.8 % | 🔒 |
| Rexel S.A. | 14.3 | 0.94 | +3.3 % | – |
| Soitec S.A. | – | 0.49 | +6.7 % | – |
| Exosens | 68.3 | 0.63 | +25.6 % | – |
| Capgemini SE | 15.3 | 0.81 | +6.5 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|